Researchers have identified a composite serum biomarker index to help with the early diagnosis of ILD in patients with systemic sclerosis. Associate Professor Tamera Corte told the Australasian Rare Lung Disease Conference 2021 that early diagnosis was essential given that interventions such as immunosuppression and antifibrotic therapies were available. She said an ideal biomarker would ...
Biomarkers predict early ILD in systemic sclerosis
By Mardi Chapman
10 Aug 2021